djh860

Buy on support

Long
djh860 Updated   
NASDAQ:ICPT   None
First product is selling very well +47% yoy sales growth, NDA for second product expected in Q3 for NASH !
The chance to first to market with a NASH drug is a huge opportunity.
Trade closed: stop reached
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.